How an integrated global network of technical, quality and customer engagement teams can support the drug development journey for biologics

Speaker: Vincenza Pironti, PhD, MBA, Global SME, Sterile Drug Products.
– End to end service to make flawless the journey from development to commercialization of biologic product
– Expertise to drive the decisions in the right way to avoid rework and wasting of time
– Network offer includes different formats such as vials and pfs/pfc but also capacities with the possibility to develop the same product on different lines but with same level of quality

Related Sites

Additional Resources